Home › Research › Topics › antibody-mediated-clearance
antibody-mediated-clearance
2 studies tagged antibody-mediated-clearance, dated 2009-03-01 to 2023-08-14. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
Studies
2 studies carry this tag.
Date range
2009 to 2023
Top journals
- CNS & neurological disorders drug targets 1
- Journal of Alzheimer's disease reports 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Immunotherapeutic efforts to slow the clinical progression of Alzheimer's disease (AD) by lowering brain amyloid-β (Aβ) have included Aβ vaccination, intravenous immunoglobulin (IVIG) products, and anti-Aβ monoclonal antibodies.
-
Immunotherapy has emerged as a leading new approach to the reduction of amyloid deposits in the brains of Alzheimer patients.